ConductScience.org, home

Paper24480331

Hydrodynamic transfection for generation of novel mouse models for liver cancer research.

Chen X and 1 other. Am J Pathol, 2014. Cited by 343 papers, by iCite.

Cite this record

ConductScience Library. Hydrodynamic transfection for generation of novel mouse models for liver cancer research. Papers, record 24480331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24480331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hydrodynamic transfection for generation of novel mouse models for liver cancer research.
PubMed
Journal
Am J Pathol
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Review
PubMed
Citations, by iCite
343
iCite
Relative citation ratio, by iCite
8.05
iCite
Revised in PubMed
2024-08-28
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen XXin
2Calvisi DFDiego F

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Disease Models, AnimalMajor topic
HydrodynamicsMajor topic
Liver NeoplasmsMajor topic
TransfectionMajor topic
Animals
Mice

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 DK026743NIDDK NIH HHSUnited StatesP30DK026743PubMed and NIHNIH RePORTER
R01 CA136606NCI NIH HHSUnited StatesR01CA136606PubMed and NIHNIH RePORTER
R01CA136606NCI NIH HHSUnited StatesR01CA136606PubMed and NIHNIH RePORTER

Download CSV of grants

References103

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120683950Synergistic role of Sprouty2 inactivation and c-Met up-regulation in mouse and human hepatocarcinogenesis.Hepatology2010https://conductscience.org/library/papers/20683950PubMed
223526421On the role of notch1 and adult hepatocytes in murine intrahepatic cholangiocarcinoma development.Hepatology2013https://conductscience.org/library/papers/23526421PubMed
321179572Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma.PLoS One2010https://conductscience.org/library/papers/21179572PubMed
418829528The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.Cancer Res2008https://conductscience.org/library/papers/18829528PubMed
516489004Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma.Cancer Res2006https://conductscience.org/library/papers/16489004PubMed
619659896Experimental mouse models for hepatocellular carcinoma research.Int J Exp Pathol2009https://conductscience.org/library/papers/19659896PubMed
721204741AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application?Expert Opin Biol Ther2011https://conductscience.org/library/papers/21204741PubMed
814529839Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo.Mol Ther2003https://conductscience.org/library/papers/14529839PubMed
918650514Sorafenib in advanced hepatocellular carcinoma.N Engl J Med2008https://conductscience.org/library/papers/18650514PubMed
1022797301Cholangiocarcinomas can originate from hepatocytes in mice.J Clin Invest2012https://conductscience.org/library/papers/22797301PubMed
1120175036Mouse models of hepatocellular carcinoma.Semin Liver Dis2010https://conductscience.org/library/papers/20175036PubMed
1211103822Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma.Cancer Res2000https://conductscience.org/library/papers/11103822PubMed
1312498772In vivo correction of murine tyrosinemia type I by DNA-mediated transposition.Mol Ther2002https://conductscience.org/library/papers/12498772PubMed
1414519650Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.Clin Cancer Res2003https://conductscience.org/library/papers/14519650PubMed
1523029524Bmi1 is required for hepatic progenitor cell expansion and liver tumor development.PLoS One2012https://conductscience.org/library/papers/23029524PubMed
1617069969Molecular pathology of biliary tract cancers.Cancer Lett2007https://conductscience.org/library/papers/17069969PubMed
1714507645Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.Am J Pathol2003https://conductscience.org/library/papers/14507645PubMed
1816818635Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.Cancer Res2006https://conductscience.org/library/papers/16818635PubMed
1919061838Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer.Cancer Cell2008https://conductscience.org/library/papers/19061838PubMed
2019319137Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma.Br J Cancer2009https://conductscience.org/library/papers/19319137PubMed

See all 103 referencesDownload CSV of references

Cited by265

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 343 citations.

PMIDTitleJournalYearIn PapersSource
42928503In Vivo CRISPR Screen Identifies RPS19 as an Immunotherapy Target in Hepatocellular Carcinoma.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42928503PubMed
42881192MAP2-mediated integrin dysregulation reprograms cancer cell plasticity in hepatocellular carcinoma.Nat Commun2026https://conductscience.org/library/papers/42881192PubMed
42792787Molecular Signaling Pathways, Regulatory and Coactivator Networks, and Emerging Mechanisms in Hepatocellular Carcinoma.Biomedicines2026https://conductscience.org/library/papers/42792787PubMed
42784692Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer.Science2026https://conductscience.org/library/papers/42784692PubMed
42722692Cancer-driver-agnostic targeting of amplified surface proteins identifies MPZL1 for selective CAR-T cell therapy.Nat Commun2026https://conductscience.org/library/papers/42722692PubMed
42468529Purine and pyrimidine-based bacterial cyclic dinucleotides egress the phagosome and activate the innate immune sensor STING.Immunity2026https://conductscience.org/library/papers/42468529PubMed
42306568Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma.Mol Ther Oncol2026https://conductscience.org/library/papers/42306568PubMed
42303608AKAP1 enhances glycogen accumulation and hepatocarcinogenesis through YTHDF2-mediated G6PC mRNA decay.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42303608PubMed
42259916Targeting cancer-specific mutations with RNA-triggered chromatin shredding.Nature2026https://conductscience.org/library/papers/42259916PubMed
42259775GABRD promotes hepatocellular carcinoma progression via the IL-10RA/JAK2-STAT3 signaling axis.Cell Death Dis2026https://conductscience.org/library/papers/42259775PubMed
42248845Histone deacetylase enzyme activity is not the universal anticancer target of HDAC inhibitors.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42248845PubMed
42207634Chaperone-mediated autophagy is a tumor-suppressive mechanism in hepatocellular carcinoma.Cell Rep2026https://conductscience.org/library/papers/42207634PubMed
42156413Integrated genomic analyses identify oncogenic pathway interplay in hepatocarcinogenesis defining specific molecular subtypes.Nat Commun2026https://conductscience.org/library/papers/42156413PubMed
42146678Selective Elimination of TP53 Mutant Cells by Transcript-Activated Chromatin Shredding.bioRxiv2026https://conductscience.org/library/papers/42146678PubMed
42118142Development of Immunoelectron Microscopy for VASN Detection Using Multiple Models and Identification of VASN as a Key Regulator of Mitochondrial Homeostasis in Hepatocellular Carcinoma Cells.FASEB J2026https://conductscience.org/library/papers/42118142PubMed
42078198How to efficiently establish animal models of cholangiocarcinoma: challenges and inspiration.Med Rev (2021)2026https://conductscience.org/library/papers/42078198PubMed
42066073Chronic stress disrupts hepatic homeostasis and accelerates liver cancer progression through ADRB2 signaling.Sci Adv2026https://conductscience.org/library/papers/42066073PubMed
41950310SLC13A2-transported citrate remodels transcriptional regulation through protein acetylation to suppress tumor growth.Sci Adv2026https://conductscience.org/library/papers/41950310PubMed
41937186Overexpression of ONECUT1 suppresses hepatoblastoma progression via modulating tumor cell growth and tumor microenvironment.Cell Biosci2026https://conductscience.org/library/papers/41937186PubMed
41928626Co-repression of Yap1 and Sox9 abrogates established cholangiocarcinoma by eliminating transcriptional compensation.Clin Mol Hepatol2026https://conductscience.org/library/papers/41928626PubMed

See all 265 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24480331

GET https://conductscience.org/api/papers/v1/24480331/references?page=2